ResMed (RMD) PT Lowered to $290 at KeyBanc
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $210.98 +1.16%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE
KeyBanc analyst Brett Fishbin lowered the price target on ResMed (NYSE: RMD) to $290.00 (from $302.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ferguson Enterprises to Join S&P 500; ADI Global Distribution to Join S&P SmallCap 600
- Thermax Ltd (TMX:IN) PT Lowered to INR5,100 at UBS
- Global Health Limited (MEDANTA:IN) PT Raised to INR1,660 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
KeyBanc, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
